Article · 18 Dec 2025
Conference abstract
Breaking down barriers to promote effective antibiotic action
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gram negative bacteria are a particular therapeutic issue as they mutate readily, and this tendency is especially common for Pseudomonas aeruginosa resulting in clinically resistant strains. To combat this problem some antibiotics are used at much higher concentrations to combat Pseudomonas. Part of the issue of admitting antibiotics into these bacteria and killing gram negative bacteria lies in the protective outer membrane, which is overlain with lipopolysaccharide, LPS. Small, branched peptides that interact with various sites in the LPS assembly with the results that the LPS change its structural mode is being developed. It is hypothesized that this may allow greater penetration of antibiotics into the bacteria. To test this idea, the method of fractional inhibitory concentration index was used to test gatifloxicin and a peptide B2099. It was found that the FICI was about 0.53 suggesting that there was synergistic action between the peptide and the gatifloxicin. Next, this combination was tested in a mouse model of corneal infection using P. aeruginosa ATCC9027 with B2099 (0.5 mg/ml), gatifloxicin (3 mg/mlthe standard ophthalmic dose), and a combination of B2099 (0.5 mg/ml) and gatifloxicin (1.5 mg/ml-half the usual dose). The result showed that the combination was significantly more active than either drug alone. Further, it was shown that B2099 interacts with lipid A to allow penetration of the gatifloxicin and the effect extends to E. coli and K. pneumonia. This unique interaction may provide a new method for killing this difficult group of pathogens.
Keywords
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Roger W Beuerman”
